Easy Availability of Marijuana and Other Cannabis-Derived Products: What is the Missouri Poison Center Seeing?
作者信息
Tominack Rebecca L, Weber Julie A
机构信息
Medical Director at Missouri Poison Center at SSM Health Cardinal Glennon Children's Hospital, St. Louis, Missouri.
Director at Missouri Poison Center at SSM Health Cardinal Glennon Children's Hospital, St. Louis, Missouri.
出版信息
Mo Med. 2024 Sep-Oct;121(5):340-344.
Abstract
摘要
相似文献
1
Easy Availability of Marijuana and Other Cannabis-Derived Products: What is the Missouri Poison Center Seeing?大麻及其他大麻衍生产品的易获取性：密苏里州中毒控制中心看到了什么？
Mo Med. 2024 Sep-Oct;121(5):340-344.
2
Characterization of edible marijuana product exposures reported to United States poison centers.向美国毒物控制中心报告的可食用大麻产品暴露情况的特征分析。
Clin Toxicol (Phila). 2016 Nov;54(9):840-846. doi: 10.1080/15563650.2016.1209761. Epub 2016 Jul 15.
3
Pediatric Cannabis Single-Substance Exposures Reported to the Michigan Poison Center From 2008-2019 After Medical Marijuana Legalization.密歇根毒物中心 2008-2019 年在医用大麻合法化后报告的儿科单一物质大麻暴露事件。
J Emerg Med. 2021 Jun;60(6):701-708. doi: 10.1016/j.jemermed.2020.12.028. Epub 2021 Feb 2.
4
Cannabis and synthetic cannabinoid poison control center cases among adults aged 50+, 2009-2019.2009-2019 年 50 岁及以上成年人的大麻和合成大麻素中毒控制中心病例。
Clin Toxicol (Phila). 2021 Apr;59(4):334-342. doi: 10.1080/15563650.2020.1806296. Epub 2020 Aug 25.
5
Marijuana Exposure Among Children Younger Than Six Years in the United States.美国6岁以下儿童接触大麻的情况。
Clin Pediatr (Phila). 2016 May;55(5):428-36. doi: 10.1177/0009922815589912. Epub 2015 Jun 7.
6
Management site and level of health care for cannabis- and synthetic cannabinoid-related poison control center cases involving older adults, 2016-2019.2016-2019 年涉及老年人的大麻和合成大麻素类中毒控制中心病例的医疗保健管理地点和级别。
Drug Chem Toxicol. 2022 Jul;45(4):1739-1747. doi: 10.1080/01480545.2020.1868494. Epub 2021 Jan 7.
7
Trends in intentional abuse and misuse ingestions in school-aged children and adolescents reported to US poison centers from 2000-2020.2000-2020 年美国中毒控制中心报告的学龄儿童和青少年故意滥用和误用药物摄入的趋势。
Clin Toxicol (Phila). 2023 Jan;61(1):64-71. doi: 10.1080/15563650.2022.2120818. Epub 2022 Dec 5.
8
A Medical & Social Catastrophe in the Making: Missouri May Legalize Addicting High THC Marijuana in 2022.一场正在形成的医学与社会灾难：密苏里州可能在2022年将高四氢大麻酚成瘾性大麻合法化。
Mo Med. 2022 Jul-Aug;119(4):308-311.
9
Sex differences in cannabis forms and exposure reasons in cannabis-related poison control center cases aged 50.50 岁及以上大麻中毒控制中心病例中大麻形式和暴露原因的性别差异
Clin Toxicol (Phila). 2021 Sep;59(9):822-831. doi: 10.1080/15563650.2020.1869756. Epub 2021 Jan 21.
10
Is Missouri going to pot? Reefer madness: legal or medical marijuana!密苏里州要乱套了？大麻狂热：合法还是医用大麻！
Mo Med. 2012 Mar-Apr;109(2):88-9.
本文引用的文献
1
Phytocannabinoids: Exploring Pharmacological Profiles and Their Impact on Therapeutical Use.植物大麻素：探索药理学特性及其对治疗应用的影响。
Int J Mol Sci. 2024 Apr 10;25(8):4204. doi: 10.3390/ijms25084204.
2
Cannabidiol-Derived Cannabinoids: The Unregulated Designer Drug Market Following the 2018 Farm Bill.大麻二酚衍生的大麻素：2018年《农业法案》后的不受监管的合成毒品市场。
Med Cannabis Cannabinoids. 2024 Feb 13;7(1):10-18. doi: 10.1159/000536339. eCollection 2024 Jan-Dec.
3
Subtle Structural Modification of a Synthetic Cannabinoid Receptor Agonist Drastically Increases its Efficacy at the CB1 Receptor.对一种合成大麻素受体激动剂进行细微的结构修饰可极大地提高其在 CB1 受体上的效力。
ACS Chem Neurosci. 2023 Nov 1;14(21):3928-3940. doi: 10.1021/acschemneuro.3c00530. Epub 2023 Oct 17.
4
Toxicity of Synthetic Cannabinoids in K2/Spice: A Systematic Review.K2/Spice中合成大麻素的毒性：一项系统评价。
Brain Sci. 2023 Jun 24;13(7):990. doi: 10.3390/brainsci13070990.
5
Delta-8, Delta-10, HHC, THC-O, THCP, and THCV: What Should We Call These Products?Delta-8、Delta-10、HHC、THC-O、THCP 和 THCV：我们应该如何称呼这些产品？
J Stud Alcohol Drugs. 2023 May;84(3):357-360. doi: 10.15288/jsad.23-00008. Epub 2023 Mar 14.
6
Unintentional ingestion of putative delta-8 tetrahydrocannabinol by two youth requiring critical care: a case report.两名青少年意外摄入疑似δ-8四氢大麻酚并需要重症监护：一例报告
J Cannabis Res. 2023 Mar 21;5(1):9. doi: 10.1186/s42238-023-00176-x.
7
Delta-8, a Cannabis-Derived Tetrahydrocannabinol Isomer: Evaluating Case Report Data in the Food and Drug Administration Adverse Event Reporting System (FAERS) Database.δ-8，一种源自大麻的四氢大麻酚异构体：评估美国食品药品监督管理局不良事件报告系统（FAERS）数据库中的病例报告数据。
Drug Healthc Patient Saf. 2023 Jan 29;15:25-38. doi: 10.2147/DHPS.S391857. eCollection 2023.
8
Delta-8 Tetrahydrocannabinol Product Impurities.德尔塔-8 四氢大麻酚产品杂质。
Molecules. 2022 Oct 15;27(20):6924. doi: 10.3390/molecules27206924.
9
Synthetic Strategies for Rare Cannabinoids Derived from .源于. 的罕见大麻素的合成策略
J Nat Prod. 2022 Jun 24;85(6):1555-1568. doi: 10.1021/acs.jnatprod.2c00155. Epub 2022 Jun 1.
10
The phytochemical diversity of commercial Cannabis in the United States.美国商业大麻的植物化学多样性。
PLoS One. 2022 May 19;17(5):e0267498. doi: 10.1371/journal.pone.0267498. eCollection 2022.
Zotero 插件